Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Annals of Neurology|August 1, 1986
Type 2 and type 3 Gaucher disease: a morphological and biochemical studyE M Kaye, M D Ullman, E R Wilson, et al.Analytical Biochemistry|May 1, 1984
Separation and quantitation of perbenzoylated glucocerebroside and galactocerebroside by high-performance liquid chromatographyE M Kaye, M D UllmanArchives of Pathology & Laboratory Medicine|January 1, 1985
Vascular involvement in type 3 neuronopathic Gaucher's diseaseE R Wilson, N W Barton, J A BarrangerAnnals of Neurology|May 1, 1988
Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlationE M Kaye, E H Kolodny, E L Logigian, et al.Neurology|December 1, 1992
Possible use of CSF glycosphingolipids for the diagnosis and therapeutic monitoring of lysosomal storage diseasesE M Kaye, M D Ullman, E H Kolodny, et al.Pediatric Research|May 1, 1983
Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storageD A Wenger, S Roth, T Kudoh, et al.Journal of Inherited Metabolic Disease|January 5, 2002
Lessons learned from the development of enzyme therapy for Gaucher diseaseJ A Barranger, E O'RourkeAnalytical Biochemistry|June 1, 1984
Nonenzymatic decarboxylation of pyruvateG Constantopoulos, J A BarrangerBiochemical Medicine|February 1, 1983
Pyruvate decarboxylating activity in extracts from pigeon liver acetone powderG Constantopoulos, J A BarrangerClinica Chimica Acta; International Journal of Clinical Chemistry|October 1, 1979
125Iodine labeling of beta-hexosaminidase A without modifying its propertiesJ W Kusiak, J A BarrangerPageof 21